Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. | 3Y returns in the bottom 25% of the category. |
INDMoney rank | - | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years | 13 Years 3 Months | ||
Fund AUM | ₹79 Cr | ₹7875 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.22% | 0.92% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 29 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.02% | 97.37% | ||
Debt % | - | - | ||
P/E | 43.16 | 34.75 | ||
P/B | 5.26 | 5.37 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -3.48% | -0.97% | ||
3-Month Return | -6.34% | -2.66% | ||
6-Month Return | -4.81% | -2.59% | ||
1-Year Return | 1.13% | 6.75% | ||
3-Year Return | 21.5% | 23.43% | ||
5-Year Return | 12.36% | 15.68% |
Sharpe | 0.84 | 0.97 | ||
Alpha | -1.5 | 0.33 | ||
Beta | 0.93 | 0.9 | ||
Standard Deviation | 15.89 | 15.32 | ||
Information Ratio | -0.71 | -0.32 |
Description | LIC MF Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Karan Doshi | Sailesh Raj Bhan, Lokesh Maru, Kinjal Desai, Divya Sharma |